BridgeMD
Compares treatment options for Stroke Sequelae
Official title Virtual Reality Versus Constraint-induced Movement on Hemiparesis in Cerebrovascular Event
ClinicalTrials.gov ID: NCT05875116
What this study is testing
- What it's testing
- The objective of this clinical trial is to measure the effect of Rehabilitation with Virtual Reality or Modified Constraint-Induced Movement Therapy on hemiparesis in patients with Cerebral Vascular Event. The question to be answered is: What is the effect of different therapeutic modalities supported by Virtual Reality or Modified Constraint-Induced Movement Therapy compared with usual Physical and Occupational Therapy on motor recovery of paretic limbs in patients with Cerebrovascular Event?
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 70
You may be able to join if
- Adult patients between 35 and 70 years of age and with a clinically and tomographically proven diagnosis of a cerebral vascular event in the...
- Patients with hemiparesis secondary to the cerebrovascular event
- Patients with a maximum Ashworth of 2 and Brunnstrom of minimum 4
- Patients with or without aphasia
- Patients with evolution between 1 to 3 months from hospital discharge of the cerebrovascular event
You likely can't join if
- Patients who develop dementia or neurological-psychomotor complications during the study.
- Patients who present a new cerebrovascular event during the investigation
- Patients who do not complete at least 90% of the program
- Patients in whom a lack of family support or secondary gain is detected.
See the full eligibility criteria
- Adult patients between 35 and 70 years of age and with a clinically and tomographically proven diagnosis of a cerebral vascular event in the territory of the middle cerebral artery.
- Patients with hemiparesis secondary to the cerebrovascular event
- Patients with a maximum Ashworth of 2 and Brunnstrom of minimum 4
- Patients with or without aphasia
- Patients with evolution between 1 to 3 months from hospital discharge of the cerebrovascular event
- Patients with cerebrovascular event of any sex
- Patients with vascular event without cognitive deficit
- Patients who agree to participate by signing an informed consent, by them or their family member or person in charge.
- Patients who develop dementia or neurological-psychomotor complications during the study.
- Patients who present a new cerebrovascular event during the investigation
- Patients who do not complete at least 90% of the program
- Patients in whom a lack of family support or secondary gain is detected.
The study team makes the final eligibility decision.
Where it's taking place
- Mexico City, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mexico City, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.